Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
DNAJB4	11080	broad.mit.edu	37	1	78470832	78470832	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr1:78470832A>G	ENST00000370763.5	+	1	295	c.38A>G	c.(37-39)aAa>aGa	p.K13R	GIPC2_ENST00000476882.1_Intron|DNAJB4_ENST00000487931.1_Intron	NM_007034.3	NP_008965.2	Q9UDY4	DNJB4_HUMAN	DnaJ (Hsp40) homolog, subfamily B, member 4	13	J.	NA			protein folding|response to heat|response to unfolded protein	cytoplasm|plasma membrane	heat shock protein binding|unfolded protein binding			endometrium(1)|kidney(1)|large_intestine(2)|lung(4)|ovary(1)|upper_aerodigestive_tract(1)	10						GGAATTGAGAAAGGAGCTTCA	0.368	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													100	112	108	NA		NA	NA	1		NA											NA				78470832		2203	4300	6503	SO:0001583	missense			ENSG00000162616	HGNC:14886		Approved	uc001dij.3	NA	B2R824|Q13431	ENST00000370763.5	37	CCDS684.1	.	.	.	.	.	.	.	.	.	.	A	7.219	0.597063	0.13875	.	.	ENSG00000162616	ENST00000426517;ENST00000370763	T;T	0.29142	1.58;1.58	5.83	5.83	0.93111	Heat shock protein DnaJ, N-terminal (5);	0.000000	0.85682	D	0.000000	T	0.04048	0.0113	N	0.00980	-1.08	0.80722	D	1	B	0.17465	0.022	B	0.26864	0.074	T	0.31861	-0.9928	10	0.02654	T	1	.	16.1885	0.81971	1.0:0.0:0.0:0.0	.	13	Q9UDY4	DNJB4_HUMAN	R	13	ENSP00000399494:K13R;ENSP00000359799:K13R	ENSP00000359799:K13R	K	+	2	0	DNAJB4	78243420	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	5.952000	0.70282	2.213000	0.71641	0.528000	0.53228	AAA	DNAJB4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000098248.3	116.215511	KEEP		+	131.209706	0.215	43	157	---	---	---	---	1	1	54	84	0	286	55	215	0	286	2	0	0	0	0	0	0	55	215	0	286	2	TP
ODF2L	57489	broad.mit.edu	37	1	86822223	86822223	+	Silent	SNP	C	C	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr1:86822223C>T	ENST00000359242.3	-	14	1703	c.1422G>A	c.(1420-1422)gcG>gcA	p.A474A	ODF2L_ENST00000370566.3_Intron|ODF2L_ENST00000294678.2_Silent_p.A445A|ODF2L_ENST00000394731.1_Silent_p.A314A|ODF2L_ENST00000524695.1_5'UTR|ODF2L_ENST00000317336.7_Silent_p.A474A|ODF2L_ENST00000370567.1_Silent_p.A445A	NM_001007022.2	NP_001007023.2	Q9ULJ1	ODF2L_HUMAN	outer dense fiber of sperm tails 2-like	474		NA				centrosome				endometrium(2)|kidney(2)|large_intestine(10)|lung(6)|ovary(1)|pancreas(1)|skin(1)|stomach(1)	24				all cancers(265;0.0313)|Epithelial(280;0.0611)		TCCGTTCCGCCGCCGTCAAGG	0.547	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								C	,,,	0,4406		0,0,2203	77	70	72	NA	1422,,,1335	-3.9	0	1		72	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous,intron,intron,coding-synonymous	ODF2L	NM_001007022.2,NM_001184765.1,NM_001184766.1,NM_020729.2	,,,	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	,,,	474/637,,,445/621	86822223	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000122417	HGNC:29225		Approved	uc001dll.2	NA	A8MU56|Q05C40|Q5BJG5|Q5TBX3|Q5TBX4|Q86X31	ENST00000359242.3	37	CCDS41354.2																																																																																			ODF2L-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000027873.2	208.836528	KEEP		-	209.282181	0.439716	62	79	---	---	---	---	1	0.9974408	2	13	0	121	100	126	0	121	2	0	0	0	0	0	0	100	126	0	121	2	TP
SSR2	6746	broad.mit.edu	37	1	155989853	155989853	+	Nonsense_Mutation	SNP	C	C	A			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr1:155989853C>A	ENST00000295702.4	-	2	177	c.106G>T	c.(106-108)Gag>Tag	p.E36*	SSR2_ENST00000496742.1_Nonsense_Mutation_p.E36*|SSR2_ENST00000480567.1_Nonsense_Mutation_p.E36*|SSR2_ENST00000529008.1_Nonsense_Mutation_p.E36*	NM_003145.3	NP_003136.1	P43308	SSRB_HUMAN	signal sequence receptor, beta (translocon-associated protein beta)	36		NA			cotranslational protein targeting to membrane	endoplasmic reticulum membrane|integral to membrane	signal sequence binding			cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(1)|lung(4)|stomach(1)	10	Hepatocellular(266;0.133)|all_hematologic(923;0.145)|all_neural(408;0.195)					TCTCGTCCCTCCACGGCGTAT	0.483	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													120	110	114	NA		NA	NA	1		NA											NA				155989853		2203	4300	6503	SO:0001587	stop_gained			ENSG00000163479	HGNC:11324	NM_003145	Approved	uc001fmx.3	NA	B2R9K9|D3DVA7|Q53HI0|Q5VY95|Q5VY96|Q6IB31|Q9BWE4	ENST00000295702.4	37	CCDS1126.1	.	.	.	.	.	.	.	.	.	.	C	27.8	4.863481	0.91511	.	.	ENSG00000163479	ENST00000295702;ENST00000529008;ENST00000496742;ENST00000480567;ENST00000531917;ENST00000526212	.	.	.	5.1	5.1	0.69264	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.19590	T	0.45	-17.9018	15.9945	0.80230	0.0:1.0:0.0:0.0	.	.	.	.	X	36	.	ENSP00000295702:E36X	E	-	1	0	SSR2	154256477	1.000000	0.71417	1.000000	0.80357	0.921000	0.55340	7.294000	0.78760	2.346000	0.79739	0.430000	0.28490	GAG	SSR2-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000046172.2	256.307578	KEEP		-	256.339727	0.48538	83	88	---	---	---	---	1	1	297	825	0	129	104	115	0	129	2	0	0	0	0	0	0	104	115	0	129	2	TP
NDUFS2	4720	broad.mit.edu	37	1	161182256	161182256	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr1:161182256C>T	ENST00000392179.4	+	10	1341	c.1102C>T	c.(1102-1104)Cga>Tga	p.R368*	NDUFS2_ENST00000465923.1_3'UTR|FCER1G_ENST00000289902.1_5'Flank|FCER1G_ENST00000367992.3_5'Flank|NDUFS2_ENST00000367993.3_Nonsense_Mutation_p.R368*	NM_001166159.1	NP_001159631.1	O75306	NDUS2_HUMAN	NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)	368		NA			mitochondrial electron transport, NADH to ubiquinone|response to oxidative stress|transport	mitochondrial respiratory chain complex I	4 iron, 4 sulfur cluster binding|electron carrier activity|metal ion binding|NAD binding|NADH dehydrogenase (ubiquinone) activity|protein binding|quinone binding			breast(2)|endometrium(1)|kidney(2)|large_intestine(3)|lung(8)|prostate(1)|skin(1)	18	all_cancers(52;1.16e-17)|all_hematologic(112;0.093)		BRCA - Breast invasive adenocarcinoma(70;0.00376)		NADH(DB00157)	TCCACCTAAGCGAGCAGAGAT	0.527	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													77	66	69	NA		NA	NA	1		NA											NA				161182256		2203	4300	6503	SO:0001587	stop_gained			ENSG00000158864	HGNC:7708	NM_004550	Approved	uc001fyw.3	NA	D3DVG7|Q5VTW0|Q969P3|Q9UEV3	ENST00000392179.4	37	CCDS53404.1	.	.	.	.	.	.	.	.	.	.	C	39	7.865975	0.98534	.	.	ENSG00000158864	ENST00000367993;ENST00000392179	.	.	.	5.16	5.16	0.70880	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1.000000	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	11.2259	0.48884	0.2954:0.7046:0.0:0.0	.	.	.	.	X	368	.	ENSP00000356972:R368X	R	+	1	2	NDUFS2	159448880	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	3.438000	0.52871	2.412000	0.81896	0.650000	0.86243	CGA	NDUFS2-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		61.564488	KEEP		+	78.28381	0.173653	29	138	---	---	---	---	1	1	10	654	0	99	33	177	0	99	2	0	0	0	0	0	0	33	177	0	99	2	TP
KIDINS220	57498	broad.mit.edu	37	2	8872006	8872006	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr2:8872006T>C	ENST00000256707.3	-	30	4341	c.4160A>G	c.(4159-4161)tAt>tGt	p.Y1387C	KIDINS220_ENST00000427284.1_Missense_Mutation_p.Y1368C|KIDINS220_ENST00000418530.1_Missense_Mutation_p.Y1288C|KIDINS220_ENST00000473731.1_Missense_Mutation_p.Y1368C	NM_020738.2	NP_065789.1	Q9ULH0	KDIS_HUMAN	kinase D-interacting substrate, 220kDa	1387		NA			activation of MAPKK activity|nerve growth factor receptor signaling pathway	cytosol|integral to membrane				NS(1)|breast(1)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(11)|lung(25)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	60	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)					GTATTCTCTATAGGCATCTCT	0.463	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													108	105	106	NA		NA	NA	2		NA											NA				8872006		1848	4100	5948	SO:0001583	missense			ENSG00000134313	HGNC:29508	NM_020738	Approved	uc002qzc.2	NA	A1L4N4|Q4VC08|Q6MZU2|Q9H889|Q9H9E4|Q9NT37|Q9UF42	ENST00000256707.3	37	CCDS42650.1	.	.	.	.	.	.	.	.	.	.	T	21.5	4.163535	0.78226	.	.	ENSG00000134313	ENST00000256707;ENST00000427284;ENST00000418530;ENST00000473731	T;T;T;T	0.81247	-1.39;-1.41;-1.47;-1.41	5.86	5.86	0.93980	.	0.000000	0.85682	D	0.000000	D	0.85630	0.5741	L	0.36672	1.1	0.58432	D	0.999998	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.97110	1.0;0.999;0.999	D	0.87188	0.2232	10	0.87932	D	0	.	16.2644	0.82568	0.0:0.0:0.0:1.0	.	1288;1387;241	Q9ULH0-2;Q9ULH0;B4DG84	.;KDIS_HUMAN;.	C	1387;1368;1288;1368	ENSP00000256707:Y1387C;ENSP00000411849:Y1368C;ENSP00000414923:Y1288C;ENSP00000418974:Y1368C	ENSP00000256707:Y1387C	Y	-	2	0	KIDINS220	8789457	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	7.499000	0.81566	2.244000	0.73946	0.528000	0.53228	TAT	KIDINS220-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000323408.2	186.921469	KEEP		-	196.03532	0.28169	60	153	---	---	---	---	1	1	87	117	0	268	73	186	0	268	2	0	0	0	0	0	0	73	186	0	268	2	TP
TMEM214	54867	broad.mit.edu	37	2	27258019	27258019	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr2:27258019T>A	ENST00000238788.9	+	3	430	c.368T>A	c.(367-369)cTg>cAg	p.L123Q	TMEM214_ENST00000404032.3_Missense_Mutation_p.L123Q	NM_017727.4	NP_060197.4	Q6NUQ4	TM214_HUMAN	transmembrane protein 214	123		NA				integral to membrane	protein binding			kidney(1)|large_intestine(5)|lung(9)|prostate(1)|skin(2)	18						GTGGCAGACCTGCAGAAGGAA	0.537	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													68	69	69	NA		NA	NA	2		NA											NA				27258019		1992	4190	6182	SO:0001583	missense			ENSG00000119777	HGNC:25983	NM_017727	Approved	uc002ria.4	NA	A6NNF2|B3KUI9|B5MCD8|D6W547|Q53SW1|Q69YH4|Q8NC45|Q8WZ37|Q9NXH2	ENST00000238788.9	37	CCDS42664.1	.	.	.	.	.	.	.	.	.	.	T	26.6	4.756308	0.89843	.	.	ENSG00000119777	ENST00000238788;ENST00000535207;ENST00000404032	D;D	0.87334	-2.24;-2.24	5.55	5.55	0.83447	.	0.000000	0.64402	D	0.000005	D	0.92535	0.7629	M	0.65498	2.005	0.58432	D	0.999997	D;D	0.76494	0.999;0.999	D;D	0.83275	0.996;0.99	D	0.93326	0.6697	10	0.87932	D	0	-8.5843	15.3575	0.74440	0.0:0.0:0.0:1.0	.	123;123	Q6NUQ4-2;Q6NUQ4	.;TM214_HUMAN	Q	123	ENSP00000238788:L123Q;ENSP00000384417:L123Q	ENSP00000238788:L123Q	L	+	2	0	TMEM214	27111523	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	7.292000	0.78731	2.107000	0.64212	0.459000	0.35465	CTG	TMEM214-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000324748.1	59.707512	KEEP		+	61.235288	0.327586	19	39	---	---	---	---	1	1	71	66	0	86	23	46	0	86	2	0	0	0	0	0	0	23	46	0	86	2	TP
SEPT10	151011	broad.mit.edu	37	2	110350668	110350668	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr2:110350668G>C	ENST00000356688.4	-	2	374	c.59C>G	c.(58-60)aCa>aGa	p.T20R	SEPT10_ENST00000415095.1_Missense_Mutation_p.T20R|SEPT10_ENST00000397712.2_Missense_Mutation_p.T20R|SEPT10_ENST00000397714.2_Intron|SEPT10_ENST00000334001.6_5'UTR|SEPT10_ENST00000545389.1_Missense_Mutation_p.T20R|SEPT10_ENST00000437928.1_Missense_Mutation_p.T5R|AC011753.5_ENST00000425576.1_RNA			Q9P0V9	SEP10_HUMAN	septin 10	20		NA			cell cycle|cell division	septin complex	GTP binding			breast(2)|endometrium(3)|large_intestine(4)|lung(8)|prostate(1)	18						CATACAAGTTGTTTTCGTTGC	0.323	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													123	118	119	NA		NA	NA	2		NA											NA				110350668		1865	4107	5972	SO:0001583	missense			ENSG00000186522	HGNC:14349	NM_144710	Approved	uc002tew.4	NA	B3KRQ9|Q86VP5|Q9HAH6	ENST00000356688.4	37		.	.	.	.	.	.	.	.	.	.	G	9.116	1.007854	0.19199	.	.	ENSG00000186522	ENST00000356688;ENST00000397712;ENST00000437928;ENST00000545389;ENST00000415095;ENST00000423520;ENST00000411469;ENST00000442746	T;T;T;T;T;T	0.56941	0.62;0.7;0.7;0.45;0.7;0.43	3.67	1.87	0.25490	.	0.660669	0.13414	N	0.389694	T	0.29458	0.0734	N	0.19112	0.55	0.09310	N	1	P;B;B	0.41041	0.736;0.294;0.17	B;B;B	0.33196	0.159;0.036;0.052	T	0.08638	-1.0712	10	0.41790	T	0.15	.	5.7735	0.18267	0.2436:0.0:0.7564:0.0	.	20;20;20	B7Z277;B5ME97;Q9P0V9	.;.;SEP10_HUMAN	R	20;20;5;20;20;20;5;11	ENSP00000349116:T20R;ENSP00000380824:T20R;ENSP00000407790:T5R;ENSP00000439364:T20R;ENSP00000396728:T20R;ENSP00000416597:T20R	ENSP00000349116:T20R	T	-	2	0	SEPT10	109707957	0.117000	0.22190	0.009000	0.14445	0.253000	0.25986	1.391000	0.34475	0.548000	0.28955	-0.136000	0.14681	ACA	SEPT10-002	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000337805.1	19.274113	KEEP		-	94.441235	0.082547	35	389	---	---	---	---	1	0.899957	9	38	0	144	50	566	0	144	2	0	0	0	0	0	0	50	566	0	144	2	TP
CERS6	253782	broad.mit.edu	37	2	169404150	169404150	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr2:169404150A>G	ENST00000305747.6	+	2	802	c.215A>G	c.(214-216)aAt>aGt	p.N72S	CERS6_ENST00000392687.4_Missense_Mutation_p.N72S	NM_203463.2	NP_982288.1	Q6ZMG9	CERS6_HUMAN	ceramide synthase 6	72		NA				endoplasmic reticulum membrane|integral to membrane|nuclear membrane	sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|sphingosine N-acyltransferase activity				NA						ATTCAGGCCAATGGACCACAA	0.413	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								A	SER/ASN	0,4406		0,0,2203	104	87	93	NA	215	-1	1	2		93	1,8599	1.2+/-3.3	0,1,4299	no	missense	CERS6	NM_203463.1	46	0,1,6502	GG,GA,AA	NA	0.0116,0.0,0.0077	benign	72/385	169404150	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000172292	HGNC:23826	NM_203463	Approved	uc002uec.2	NA	Q8N617	ENST00000305747.6	37	CCDS2228.1	.	.	.	.	.	.	.	.	.	.	A	4.474	0.087774	0.08583	0.0	1.16E-4	ENSG00000172292	ENST00000305747;ENST00000392687	T;T	0.21191	2.02;2.02	5.68	-1.04	0.10068	.	0.167448	0.64402	N	0.000004	T	0.06508	0.0167	N	0.03016	-0.435	0.54753	D	0.999982	B;B	0.06786	0.0;0.001	B;B	0.06405	0.0;0.002	T	0.42565	-0.9444	10	0.06891	T	0.86	-26.2634	10.8501	0.46765	0.5237:0.0:0.4763:0.0	.	72;72	Q32M63;Q6ZMG9	.;CERS6_HUMAN	S	72	ENSP00000306579:N72S;ENSP00000376453:N72S	ENSP00000306579:N72S	N	+	2	0	CERS6	169112396	1.000000	0.71417	0.991000	0.47740	0.955000	0.61496	0.887000	0.28254	-0.413000	0.07507	-0.911000	0.02809	AAT	CERS6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255235.2	1.463791	KEEP		+	38.259841	0.075377	15	184	---	---	---	---	1	0.9169593	3	51	0	64	22	267	0	64	2	0	0	0	0	0	0	22	267	0	64	2	TP
IDH1	3417	broad.mit.edu	37	2	209113112	209113112	+	Missense_Mutation	SNP	C	C	T	rs121913500		GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr2:209113112C>T	ENST00000415913.1	-	4	776	c.395G>A	c.(394-396)cGt>cAt	p.R132H	IDH1_ENST00000446179.1_Missense_Mutation_p.R132H|IDH1_ENST00000345146.2_Missense_Mutation_p.R132H			O75874	IDHC_HUMAN	isocitrate dehydrogenase 1 (NADP+), soluble	132		NA	R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).		2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle	cytosol|peroxisomal matrix	isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity	p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1)		NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1)	4887				Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136)		ATAAGCATGACGACCTATGAT	0.393	NA	NA	Mis		gliobastoma		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(158;264 1958 3300 35450 36047)		Dom	yes		2	2q33.3	3417	"""isocitrate dehydrogenase 1 (NADP+), soluble"""	NA	O	2835	Substitution - Missense(2834)|Complex - compound substitution(1)	central_nervous_system(2579)|haematopoietic_and_lymphoid_tissue(205)|bone(43)|prostate(4)|biliary_tract(2)|urinary_tract(1)|skin(1)											79	73	75	NA		NA	NA	2		NA											NA				209113112		2203	4300	6503	SO:0001583	missense			ENSG00000138413	HGNC:5382		Approved	uc002vcu.3	NA	Q7Z3V0|Q93090|Q9NTJ9|Q9UKW8	ENST00000415913.1	37	CCDS2381.1	.	.	.	.	.	.	.	.	.	.	C	25.6	4.657324	0.88154	.	.	ENSG00000138413	ENST00000345146;ENST00000446179;ENST00000415913;ENST00000415282	D;D;D;D	0.86956	-2.19;-2.19;-2.19;-2.19	5.57	4.69	0.59074	Isopropylmalate dehydrogenase-like domain (2);	0.000000	0.85682	D	0.000000	D	0.93145	0.7817	H	0.99379	4.54	0.80722	D	1	B	0.25486	0.127	B	0.25405	0.06	D	0.92324	0.5868	10	0.87932	D	0	-20.0399	14.3783	0.66895	0.0:0.9288:0.0:0.0712	.	132	O75874	IDHC_HUMAN	H	132	ENSP00000260985:R132H;ENSP00000410513:R132H;ENSP00000390265:R132H;ENSP00000391075:R132H	ENSP00000260985:R132H	R	-	2	0	IDH1	208821357	1.000000	0.71417	0.997000	0.53966	0.992000	0.81027	6.088000	0.71371	1.356000	0.45884	0.555000	0.69702	CGT	IDH1-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336672.1	72.205999	KEEP		-	76.592857	0.273684	26	69	---	---	---	---	1	1	75	144	0	133	36	81	0	133	2	1	0.3680922	2	2	0	4	36	81	0	133	2	TP
ZNF142	7701	broad.mit.edu	37	2	219521105	219521105	+	Silent	SNP	C	C	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr2:219521105C>T	ENST00000411696.2	-	3	827	c.48G>A	c.(46-48)gaG>gaA	p.E16E	ZNF142_ENST00000449707.1_Silent_p.E16E			P52746	ZN142_HUMAN	zinc finger protein 142	16		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(7)|endometrium(7)|large_intestine(5)|lung(12)|ovary(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)	38		Renal(207;0.0474)		Epithelial(149;5.21e-07)|all cancers(144;0.000106)|LUSC - Lung squamous cell carcinoma(224;0.008)|Lung(261;0.00948)		GTCCATCCATCTCCCCGGTGC	0.582	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(170;867 1942 8995 15834 18053)					NA		NA		NA		0													55	61	59	NA		NA	NA	2		NA											NA				219521105		1974	4143	6117	SO:0001819	synonymous_variant			ENSG00000115568	HGNC:12927	NM_005081	Approved	uc002vin.4	NA	Q92510	ENST00000411696.2	37	CCDS42817.1	.	.	.	.	.	.	.	.	.	.	C	6.012	0.370536	0.11352	.	.	ENSG00000115568	ENST00000440934	.	.	.	4.69	2.65	0.31530	.	.	.	.	.	T	0.55940	0.1952	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.51172	-0.8739	4	.	.	.	-1.7294	7.563	0.27862	0.0:0.7248:0.1728:0.1024	.	.	.	.	N	8	.	.	D	-	1	0	ZNF142	219229349	1.000000	0.71417	1.000000	0.80357	0.611000	0.37282	0.691000	0.25467	1.139000	0.42245	0.563000	0.77884	GAT	ZNF142-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		102.751756	KEEP		-	102.75546	0.508475	30	29	---	---	---	---	1	0.9927748	6	7	1	100	38	46	1	100	2	0	0	0	0	0	0	38	46	1	100	2	TP
FANCD2	2177	broad.mit.edu	37	3	10067765	10067765	+	5'Flank	SNP	C	C	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr3:10067765C>G	ENST00000287647.3	+	0	0				FANCD2_ENST00000431693.1_5'Flank|CIDECP_ENST00000432401.1_RNA|FANCD2_ENST00000383806.1_5'Flank|FANCD2_ENST00000383807.1_5'Flank|FANCD2_ENST00000419585.1_5'Flank	NM_033084.3	NP_149075.2	Q9BXW9	FACD2_HUMAN	Fanconi anemia, complementation group D2	NA		NA			DNA repair|response to gamma radiation	nucleoplasm	protein binding			NS(1)|breast(3)|central_nervous_system(3)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(11)|lung(10)|ovary(1)|prostate(3)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(3)	51				OV - Ovarian serous cystadenocarcinoma(96;0.148)		TTGTCGCTCTCCAGCAGGATG	0.557	NA	NA	"""D, Mis, N, F"""			"""AML, leukemia"""	NA	Involved in tolerance or repair of DNA crosslinks	Fanconi Anemia					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec		Fanconi anaemia D2	3	3p26	2177	"""Fanconi anemia, complementation group D2"""	NA	L	0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001631	upstream_gene_variant	Familial Cancer Database	Pancytopenia Dysmelia, FA (several complementation groups)	ENSG00000144554	HGNC:3585		Approved	uc003buw.3	NA	Q2LA86|Q69YP9|Q6PJN7|Q9BQ06|Q9H9T9	ENST00000287647.3	37	CCDS2595.1																																																																																			FANCD2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250562.2	-15.196813	KEEP		+	6.694961	0.032609	3	89	---	---	---	---	1	0.8821575	43	121	0	70	3	124	0	70	2	0	0	0	0	0	0	3	124	0	70	2	TP
NICN1	84276	broad.mit.edu	37	3	49463788	49463788	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr3:49463788T>G	ENST00000273598.3	-	2	292	c.206A>C	c.(205-207)cAc>cCc	p.H69P	NICN1_ENST00000436744.2_Missense_Mutation_p.H69P|NICN1_ENST00000422593.1_5'UTR|NICN1-AS1_ENST00000424915.1_RNA	NM_032316.3	NP_115692.1	Q9BSH3	NICN1_HUMAN	nicolin 1	69		NA				microtubule|nucleus				kidney(1)|large_intestine(3)|lung(1)	5				BRCA - Breast invasive adenocarcinoma(193;4.52e-05)|Kidney(197;0.00217)|KIRC - Kidney renal clear cell carcinoma(197;0.00244)		GGCAGGTGTGTGTGCTGAGGT	0.498	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													98	82	87	NA		NA	NA	3		NA											NA				49463788		2203	4300	6503	SO:0001583	missense			ENSG00000145029	HGNC:18317	NM_032316	Approved	uc003cwz.1	NA	Q8IZQ2	ENST00000273598.3	37	CCDS2798.1	.	.	.	.	.	.	.	.	.	.	T	8.060	0.767916	0.15983	.	.	ENSG00000145029	ENST00000273598;ENST00000430622;ENST00000436744	T;T	0.24538	1.85;1.85	5.3	5.3	0.74995	.	0.211030	0.40144	N	0.001164	T	0.33206	0.0855	L	0.34521	1.04	0.25069	N	0.991006	D;D	0.64830	0.987;0.994	P;P	0.56865	0.6;0.808	T	0.11991	-1.0565	10	0.45353	T	0.12	-15.6021	13.1802	0.59649	0.0:0.0:0.0:1.0	.	69;69	B4DX77;Q9BSH3	.;NICN1_HUMAN	P	69	ENSP00000273598:H69P;ENSP00000402335:H69P	ENSP00000273598:H69P	H	-	2	0	NICN1	49438792	0.577000	0.26708	0.092000	0.20876	0.016000	0.09150	1.022000	0.30052	2.012000	0.59069	0.533000	0.62120	CAC	NICN1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000346224.3	22.17973	KEEP		-	24.928309	0.216216	8	29	---	---	---	---	1	0.9999574	15	74	0	101	9	32	0	101	2	0	0	0	0	0	0	9	32	0	101	2	TP
C3orf17	25871	broad.mit.edu	37	3	112724550	112724550	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr3:112724550T>C	ENST00000314400.5	-	9	1728	c.1537A>G	c.(1537-1539)Atg>Gtg	p.M513V	C3orf17_ENST00000383675.2_Missense_Mutation_p.M443V|C3orf17_ENST00000393857.2_Missense_Mutation_p.M377V|C3orf17_ENST00000472762.1_5'Flank	NM_015412.3	NP_056227.2	Q6NW34	CC017_HUMAN	chromosome 3 open reading frame 17	513		NA				integral to membrane				central_nervous_system(1)|endometrium(1)|kidney(2)|lung(6)|prostate(2)|skin(1)	13						ATGACAGGCATTGAAACTCCA	0.388	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													157	148	151	NA		NA	NA	3		NA											NA				112724550		2203	4300	6503	SO:0001583	missense			ENSG00000163608	HGNC:24496	NM_015412	Approved	uc003dzr.3	NA	D3DN69|Q68DM6|Q9H7U0|Q9UFM4	ENST00000314400.5	37	CCDS33824.1	.	.	.	.	.	.	.	.	.	.	T	5.508	0.278619	0.10458	.	.	ENSG00000163608	ENST00000314400;ENST00000383675;ENST00000412848;ENST00000393857	T;T;T	0.28895	1.59;1.59;1.59	5.18	-3.45	0.04781	.	2.020510	0.01969	N	0.043917	T	0.11495	0.0280	N	0.02011	-0.69	0.09310	N	1	B;B;B;B	0.02656	0.0;0.0;0.0;0.0	B;B;B;B	0.04013	0.0;0.0;0.001;0.0	T	0.15378	-1.0439	10	0.27082	T	0.32	1.014	5.3811	0.16192	0.0:0.3139:0.2693:0.4168	.	402;310;443;513	E7EN80;E7EQH6;Q6NW34-2;Q6NW34	.;.;.;CC017_HUMAN	V	513;443;160;377	ENSP00000320251:M513V;ENSP00000373173:M443V;ENSP00000377438:M377V	ENSP00000320251:M513V	M	-	1	0	C3orf17	114207240	0.000000	0.05858	0.000000	0.03702	0.002000	0.02628	-0.257000	0.08745	-0.666000	0.05310	-0.274000	0.10170	ATG	C3orf17-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000354405.3	597.401292	KEEP		-	605.582353	0.364	182	318	---	---	---	---	1	1	52	81	0	248	223	401	0	248	2	0	0	0	0	0	0	223	401	0	248	2	TP
LGI2	55203	broad.mit.edu	37	4	25019723	25019723	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr4:25019723C>A	ENST00000382114.4	-	6	728	c.543G>T	c.(541-543)tgG>tgT	p.W181C		NM_018176.3	NP_060646.2	Q8N0V4	LGI2_HUMAN	leucine-rich repeat LGI family, member 2	181	LRRCT.	NA				extracellular region				breast(2)|endometrium(2)|kidney(2)|large_intestine(6)|lung(15)|prostate(1)|skin(3)|stomach(2)	33		Breast(46;0.173)				TCATCTTCAACCACAGGTATA	0.373	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													184	171	175	NA		NA	NA	4		NA											NA				25019723		2203	4300	6503	SO:0001583	missense			ENSG00000153012	HGNC:18710		Approved	uc003grf.2	NA	Q3MIN2|Q8NDW6|Q96PX2|Q9NVK4	ENST00000382114.4	37	CCDS3431.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	23.4|23.4	4.417110|4.417110	0.83449|0.83449	.|.	.|.	ENSG00000153012|ENSG00000153012	ENST00000512108|ENST00000382114	.|D	.|0.91740	.|-2.9	5.65|5.65	5.65|5.65	0.86999|0.86999	.|Cysteine-rich flanking region, C-terminal (1);	.|0.000000	.|0.85682	.|D	.|0.000000	D|D	0.97129|0.97129	0.9062|0.9062	M|M	0.91612|0.91612	3.225|3.225	0.80722|0.80722	D|D	1|1	.|D	.|0.89917	.|1.0	.|D	.|0.83275	.|0.996	D|D	0.97286|0.97286	0.9921|0.9921	5|10	.|0.72032	.|D	.|0.01	-17.0959|-17.0959	20.0781|20.0781	0.97751|0.97751	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	.|181	.|Q8N0V4	.|LGI2_HUMAN	V|C	172|181	.|ENSP00000371548:W181C	.|ENSP00000371548:W181C	G|W	-|-	2|3	0|0	LGI2|LGI2	24628821|24628821	1.000000|1.000000	0.71417|0.71417	0.999000|0.999000	0.59377|0.59377	0.997000|0.997000	0.91878|0.91878	7.776000|7.776000	0.85560|0.85560	2.817000|2.817000	0.96982|0.96982	0.563000|0.563000	0.77884|0.77884	GGT|TGG	LGI2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000214978.1	322.259396	KEEP		-	322.260077	0.497585	103	104	---	---	---	---	1	1	19	15	0	295	118	125	0	295	2	0	0	0	0	0	0	118	125	0	295	2	TP
UGT2A3	79799	broad.mit.edu	37	4	69798344	69798344	+	Splice_Site	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr4:69798344A>G	ENST00000251566.4	-	3	1027		c.e3+1		UGT2A3_ENST00000420231.2_Splice_Site	NM_024743.3	NP_079019.3	Q6UWM9	UD2A3_HUMAN	UDP glucuronosyltransferase 2 family, polypeptide A3	NA		NA				integral to membrane	glucuronosyltransferase activity			NS(1)|breast(1)|central_nervous_system(1)|kidney(5)|large_intestine(7)|lung(16)|ovary(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	36						GGTTTTACTGACCTTCTGTGG	0.398	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													140	137	138	NA		NA	NA	4		NA											NA				69798344		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000135220	HGNC:28528	NM_024743	Approved	uc003hef.2	NA	Q9H6S4	ENST00000251566.4	37	CCDS3525.1	.	.	.	.	.	.	.	.	.	.	-	14.17	2.455256	0.43634	.	.	ENSG00000135220	ENST00000251566;ENST00000420231	.	.	.	2.08	2.08	0.27032	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.7361	0.28815	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	-	.	.	UGT2A3	69832933	1.000000	0.71417	0.806000	0.32338	0.284000	0.27059	7.491000	0.81471	0.948000	0.37687	0.459000	0.35465	.	UGT2A3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251564.1	-8.807783	KEEP	Intron	-	85.618695	0.067623	33	455	---	---	---	---	0	0	0	0	0	380	46	604	0	380	2	1	0.9999663	20	177	0	179	46	604	0	380	2	TP
PCDH18	54510	broad.mit.edu	37	4	138442804	138442804	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr4:138442804G>T	ENST00000344876.4	-	4	3173	c.2787C>A	c.(2785-2787)gaC>gaA	p.D929E	PCDH18_ENST00000511115.1_Missense_Mutation_p.D109E|PCDH18_ENST00000510305.1_Missense_Mutation_p.D140E|PCDH18_ENST00000507846.1_Missense_Mutation_p.D708E|PCDH18_ENST00000412923.2_Missense_Mutation_p.D928E	NM_019035.3	NP_061908.1	Q9HCL0	PCD18_HUMAN	protocadherin 18	929	Interaction with DAB1 (By similarity).	NA			brain development|homophilic cell adhesion	integral to membrane|plasma membrane	calcium ion binding			NS(1)|breast(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(27)|lung(21)|ovary(2)|pancreas(4)|prostate(3)|skin(12)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(1)	86	all_hematologic(180;0.24)					TCCAGCACTGGTCAGAGTGTC	0.498	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													132	131	131	NA		NA	NA	4		NA											NA				138442804		2203	4300	6503	SO:0001583	missense			ENSG00000189184	HGNC:14268	NM_019035	Approved	uc003ihe.4	NA	A8K7K3|B7ZKT1|Q52LS2	ENST00000344876.4	37	CCDS34064.1	.	.	.	.	.	.	.	.	.	.	G	17.97	3.518315	0.64634	.	.	ENSG00000189184	ENST00000344876;ENST00000412923;ENST00000507846;ENST00000510305;ENST00000511115	D;D;D;T;T	0.83591	-1.69;-1.68;-1.74;-0.49;-0.45	5.55	4.71	0.59529	.	0.000000	0.45867	D	0.000337	D	0.91314	0.7261	M	0.84948	2.725	0.52099	D	0.999943	D;D;D;D	0.89917	1.0;0.999;1.0;0.999	D;D;D;D	0.91635	0.999;0.991;0.992;0.991	D	0.91429	0.5164	10	0.42905	T	0.14	.	14.6088	0.68501	0.07:0.0:0.93:0.0	.	109;708;928;929	B4DLR6;D6RIG4;Q9HCL0-2;Q9HCL0	.;.;.;PCD18_HUMAN	E	929;928;708;140;109	ENSP00000355082:D929E;ENSP00000390688:D928E;ENSP00000425903:D708E;ENSP00000424269:D140E;ENSP00000425647:D109E	ENSP00000355082:D929E	D	-	3	2	PCDH18	138662254	1.000000	0.71417	1.000000	0.80357	0.968000	0.65278	4.141000	0.58038	1.358000	0.45922	-0.137000	0.14449	GAC	PCDH18-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000364614.1	175.271679	KEEP		-	208.715163	0.191489	72	304	---	---	---	---	1	0.9933129	9	26	0	371	98	418	0	371	2	0	0	0	0	0	0	98	418	0	371	2	TP
MFAP3L	9848	broad.mit.edu	37	4	170926952	170926952	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr4:170926952G>A	ENST00000361618.3	-	2	384	c.77C>T	c.(76-78)gCc>gTc	p.A26V	MFAP3L_ENST00000393704.3_5'Flank|MFAP3L_ENST00000506110.1_Missense_Mutation_p.A26V|MFAP3L_ENST00000393702.3_Missense_Mutation_p.A26V	NM_021647.6	NP_067679.6	O75121	MFA3L_HUMAN	microfibrillar-associated protein 3-like	26		NA				integral to membrane|plasma membrane				cervix(1)|endometrium(4)|kidney(1)|large_intestine(6)|lung(5)|ovary(1)|pancreas(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	22		Prostate(90;0.00601)|Renal(120;0.0183)|all_neural(102;0.122)|Melanoma(52;0.17)		GBM - Glioblastoma multiforme(119;0.0201)|LUSC - Lung squamous cell carcinoma(193;0.116)		CTTAGCGGTGGCTAGAGTGGA	0.458	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													100	100	100	NA		NA	NA	4		NA											NA				170926952		2203	4300	6503	SO:0001583	missense				HGNC:29083	NM_021647	Approved	uc003isp.4	NA	A8K1X6|D3DP35|Q4W5N7|Q4W5N9|Q6TNA8|Q9BVE1|Q9BXK0	ENST00000361618.3	37	CCDS34103.1	.	.	.	.	.	.	.	.	.	.	G	13.99	2.403205	0.42613	.	.	ENSG00000198948	ENST00000361618;ENST00000393702;ENST00000506110;ENST00000504999;ENST00000506764;ENST00000510306	D;D;D;D;D	0.86164	-1.79;-2.08;-2.08;-2.08;-1.82	5.58	4.72	0.59763	.	0.274739	0.37483	N	0.002074	D	0.84561	0.5499	M	0.69823	2.125	0.19575	N	0.999966	P	0.39282	0.666	B	0.33339	0.162	T	0.75977	-0.3127	10	0.31617	T	0.26	0.738	14.925	0.70871	0.0:0.1426:0.8574:0.0	.	26	O75121	MFA3L_HUMAN	V	26	ENSP00000354583:A26V;ENSP00000377305:A26V;ENSP00000422571:A26V;ENSP00000425303:A26V;ENSP00000426247:A26V	ENSP00000354583:A26V	A	-	2	0	MFAP3L	171163527	0.098000	0.21812	0.164000	0.22755	0.004000	0.04260	1.276000	0.33156	1.429000	0.47314	0.655000	0.94253	GCC	MFAP3L-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000363043.2	179.672715	KEEP		-	182.460458	0.701299	54	23	---	---	---	---	1	1	22	21	0	118	75	39	0	118	2	0	0	0	0	0	0	75	39	0	118	2	TP
KIAA0319	9856	broad.mit.edu	37	6	24563608	24563608	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr6:24563608A>G	ENST00000535378.1	-	17	3185	c.2543T>C	c.(2542-2544)aTt>aCt	p.I848T	KIAA0319_ENST00000537886.1_Missense_Mutation_p.I857T|KIAA0319_ENST00000378214.3_Missense_Mutation_p.I857T|KIAA0319_ENST00000430948.2_Missense_Mutation_p.I812T|KIAA0319_ENST00000543707.1_Missense_Mutation_p.I857T	NM_001168374.1	NP_001161846.1	Q5VV43	K0319_HUMAN	KIAA0319	857		NA			negative regulation of dendrite development|neuron migration	early endosome membrane|integral to membrane|plasma membrane	protein binding			breast(3)|endometrium(6)|kidney(3)|large_intestine(11)|lung(19)|ovary(1)|prostate(3)|skin(6)|upper_aerodigestive_tract(1)	53						GTGGGCCCGAATCTTCTGGAC	0.567	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													75	62	66	NA		NA	NA	6		NA											NA				24563608		2203	4300	6503	SO:0001583	missense			ENSG00000137261	HGNC:21580	NM_014809	Approved	uc003neh.1	NA	A7MD37|B2RTU7|B4DHA7|B4DK75|Q9UJC8|Q9Y4G7	ENST00000535378.1	37	CCDS54970.1	.	.	.	.	.	.	.	.	.	.	A	17.89	3.500600	0.64298	.	.	ENSG00000137261	ENST00000537886;ENST00000535378;ENST00000430948;ENST00000378214;ENST00000543707	T;T;T;T;T	0.10960	2.83;2.83;2.83;2.82;2.82	4.23	4.23	0.50019	.	0.075313	0.53938	D	0.000053	T	0.17746	0.0426	M	0.76328	2.33	0.50813	D	0.999899	D;P;P	0.63046	0.992;0.925;0.877	P;P;B	0.57101	0.813;0.536;0.335	T	0.01416	-1.1360	10	0.87932	D	0	-20.0534	13.4883	0.61379	1.0:0.0:0.0:0.0	.	857;848;857	F5H123;Q5VV43-2;Q5VV43	.;.;K0319_HUMAN	T	857;848;812;857;857	ENSP00000439700:I857T;ENSP00000442403:I848T;ENSP00000401086:I812T;ENSP00000367459:I857T;ENSP00000437656:I857T	ENSP00000367459:I857T	I	-	2	0	KIAA0319	24671587	1.000000	0.71417	1.000000	0.80357	0.968000	0.65278	8.087000	0.89521	1.754000	0.51921	0.533000	0.62120	ATT	KIAA0319-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		30.158342	KEEP		-	48.884186	0.128571	18	122	---	---	---	---	1	0.2360197	2	4	0	113	27	151	0	113	2	0	0	0	0	0	0	27	151	0	113	2	TP
BTN2A3P	0	broad.mit.edu	37	6	26422353	26422353	+	RNA	SNP	C	C	T	rs141013110		GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr6:26422353C>T	ENST00000466808.2	+	0	7										NA		NA						p.P3S(2)			NA						GCTCATGGAACCAGCTGCTGC	0.622	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		2	Substitution - Missense(2)	endometrium(1)|kidney(1)											NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA										NA		ENST00000466808.2	37																																																																																				BTN2A3P-001	KNOWN	basic	processed_transcript	NA	pseudogene	OTTHUMT00000040118.4	-78.087465	KEEP		+	7.903097	0.01548	5	318	---	---	---	---	1	0.2442849	13	14	0	203	6	378	0	203	2	0	0	0	0	0	0	6	378	0	203	2	TP
POLR3D	661	broad.mit.edu	37	8	22106020	22106020	+	Silent	SNP	C	C	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr8:22106020C>T	ENST00000397802.4	+	5	728	c.513C>T	c.(511-513)aaC>aaT	p.N171N	POLR3D_ENST00000306433.4_Silent_p.N171N			P05423	RPC4_HUMAN	polymerase (RNA) III (DNA directed) polypeptide D, 44kDa	171		NA			innate immune response|positive regulation of innate immune response|positive regulation of interferon-beta production|response to virus|termination of RNA polymerase III transcription|transcription elongation from RNA polymerase III promoter	DNA-directed RNA polymerase III complex	DNA binding|DNA-directed RNA polymerase activity			central_nervous_system(1)|endometrium(1)|large_intestine(4)|lung(5)|prostate(1)|stomach(1)	13				Colorectal(74;0.0146)|COAD - Colon adenocarcinoma(73;0.061)		GCCTGAGGAACGACACTCGAA	0.527	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													89	96	94	NA		NA	NA	8		NA											NA				22106020		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000168495	HGNC:1080	NM_001722	Approved	uc003xbl.3	NA	Q6FI28|Q9BPV7|Q9BPZ1|Q9BXB3	ENST00000397802.4	37	CCDS34858.1																																																																																			POLR3D-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000375434.2	121.503543	KEEP		+	134.423384	0.237864	49	157	---	---	---	---	1	1	24	81	0	219	55	183	0	219	2	0	0	0	0	0	0	55	183	0	219	2	TP
NCALD	83988	broad.mit.edu	37	8	102705056	102705056	+	Silent	SNP	T	T	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr8:102705056T>C	ENST00000395923.1	-	5	906	c.447A>G	c.(445-447)acA>acG	p.T149T	NCALD_ENST00000220931.6_Silent_p.T149T|NCALD_ENST00000522951.1_Silent_p.T149T|NCALD_ENST00000311028.3_Silent_p.T149T|NCALD_ENST00000521599.1_Silent_p.T149T|NCALD_ENST00000519508.2_Silent_p.T149T	NM_001040627.1|NM_001040628.1|NM_001040629.1|NM_001040630.1	NP_001035717.1|NP_001035718.1|NP_001035719.1|NP_001035720.1	P61601	NCALD_HUMAN	neurocalcin delta	149	EF-hand 4.	NA			synaptic transmission|vesicle-mediated transport	clathrin coat of trans-Golgi network vesicle|cytosol	actin binding|calcium ion binding|clathrin binding|tubulin binding			endometrium(1)|large_intestine(2)|lung(4)|prostate(1)	8	all_cancers(14;8.94e-08)|all_epithelial(15;7.03e-10)|Lung NSC(17;1.36e-05)|all_lung(17;2.7e-05)		all cancers(13;1.09e-06)|OV - Ovarian serous cystadenocarcinoma(57;0.000699)			AGATCTTTTCTGTTCTTTTCT	0.507	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													168	158	161	NA		NA	NA	8		NA											NA				102705056		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:7655		Approved	uc003ykk.3	NA	P29554|Q8IYC3|Q9H0W2	ENST00000395923.1	37	CCDS6292.1																																																																																			NCALD-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		263.384029	KEEP		-	266.715107	0.37395	89	149	---	---	---	---	1	0.9999995	16	24	0	154	115	189	0	154	2	0	0	0	0	0	0	115	189	0	154	2	TP
ANKRD20A4	728747	broad.mit.edu	37	9	69424177	69424177	+	3'UTR	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr9:69424177A>G	ENST00000357336.3	+	0	2754					NM_001098805.1	NP_001092275.1	Q4UJ75	A20A4_HUMAN	ankyrin repeat domain 20 family, member A4	NA		NA								breast(1)|large_intestine(1)|liver(1)|lung(9)|pancreas(2)|skin(2)	16						GAAAATTTAAACATTTGGTTC	0.279	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													10	12	11	NA		NA	NA	9		NA											NA				69424177		545	1740	2285	SO:0001624	3_prime_UTR_variant			ENSG00000172014	HGNC:31982	NM_001098805	Approved	uc004afn.3	NA		ENST00000357336.3	37	CCDS43828.1																																																																																			ANKRD20A4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000143287.3	19.168994	KEEP		+	24.670846	0.16	8	42	---	---	---	---	1	0.03173077	2	0	0	103	10	52	0	103	2	0	0	0	0	0	0	10	52	0	103	2	TP
FXN	2395	broad.mit.edu	37	9	71687595	71687595	+	Nonsense_Mutation	SNP	G	G	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr9:71687595G>T	ENST00000377270.3	+	5	1074	c.550G>T	c.(550-552)Gag>Tag	p.E184*	FXN_ENST00000396366.2_Missense_Mutation_p.M186I|FXN_ENST00000498653.1_Nonsense_Mutation_p.E109*|FXN_ENST00000396364.3_Intron	NM_000144.4	NP_000135.2	Q16595	FRDA_HUMAN	frataxin	184		NA			cellular iron ion homeostasis|cellular response to hydrogen peroxide|heme biosynthetic process|ion transport|iron incorporation into metallo-sulfur cluster|negative regulation of apoptosis|negative regulation of release of cytochrome c from mitochondria|positive regulation of cell growth|positive regulation of cell proliferation|positive regulation of lyase activity|positive regulation of metalloenzyme activity|positive regulation of oxidoreductase activity|positive regulation of transferase activity|protein autoprocessing|regulation of ferrochelatase activity|response to iron ion	cytosol|mitochondrial matrix	2 iron, 2 sulfur cluster binding|ferric iron binding|ferrous iron binding|ferroxidase activity|iron chaperone activity|protein binding			large_intestine(1)|lung(1)	2						GTCCCTCCATGAGCTGCTGGC	0.498	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													119	102	108	NA		NA	NA	9		NA											NA				71687595		2203	4300	6503	SO:0001587	stop_gained			ENSG00000165060	HGNC:3951	NM_000144	Approved	uc004aha.2	NA	O15545|O95656|Q15294|Q5VZ01	ENST00000377270.3	37	CCDS6626.1	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	G|G|G	13.52|13.52|13.52	2.263156|2.263156|2.263156	0.39995|0.39995|0.39995	.|.|.	.|.|.	ENSG00000165060|ENSG00000165060|ENSG00000165060	ENST00000377270;ENST00000498653|ENST00000396366|ENST00000484259	.|D|.	.|0.95622|.	.|-3.76|.	4.87|4.87|4.87	1.91|1.91|1.91	0.25777|0.25777|0.25777	.|.|.	0.435914|.|.	0.25461|.|.	N|.|.	0.030517|.|.	.|T|.	.|0.69333|.	.|0.3099|.	.|.|.	.|.|.	.|.|.	0.80722|0.80722|0.80722	D|D|D	1|1|1	.|B|.	.|0.12013|.	.|0.005|.	.|B|.	.|0.09377|.	.|0.004|.	.|T|.	.|0.66795|.	.|-0.5833|.	.|8|.	0.38643|0.39692|.	T|T|.	0.18|0.17|.	-8.8717|-8.8717|-8.8717	15.522|15.522|15.522	0.75874|0.75874|0.75874	0.0:0.4531:0.5469:0.0|0.0:0.4531:0.5469:0.0|0.0:0.4531:0.5469:0.0	.|.|.	.|186|.	.|A8MXJ6|.	.|.|.	X|I|L	184;109|186|81	.|ENSP00000379652:M186I|.	ENSP00000366482:E184X|ENSP00000379652:M186I|.	E|M|X	+|+|+	1|3|2	0|0|2	FXN|FXN|FXN	70877415|70877415|70877415	1.000000|1.000000|1.000000	0.71417|0.71417|0.71417	0.871000|0.871000|0.871000	0.34182|0.34182|0.34182	0.625000|0.625000|0.625000	0.37756|0.37756|0.37756	2.559000|2.559000|2.559000	0.45888|0.45888|0.45888	0.093000|0.093000|0.093000	0.17368|0.17368|0.17368	0.563000|0.563000|0.563000	0.77884|0.77884|0.77884	GAG|ATG|TGA	FXN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052568.2	43.352441	KEEP		+	70.045088	0.135266	28	179	---	---	---	---	1	0.999995	26	101	0	183	34	222	0	183	2	0	0	0	0	0	0	34	222	0	183	2	TP
TDRD7	23424	broad.mit.edu	37	9	100235814	100235814	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr9:100235814G>T	ENST00000355295.4	+	11	2280	c.1985G>T	c.(1984-1986)tGc>tTc	p.C662F	TDRD7_ENST00000540902.1_Missense_Mutation_p.C11F|TDRD7_ENST00000422139.2_Missense_Mutation_p.C588F	NM_014290.2	NP_055105.2	Q8NHU6	TDRD7_HUMAN	tudor domain containing 7	662		NA			lens fiber cell differentiation|lens morphogenesis in camera-type eye|posttranscriptional regulation of gene expression|spermatogenesis	chromatoid body	mRNA binding			endometrium(3)|kidney(4)|large_intestine(6)|lung(8)|ovary(2)|pancreas(1)|prostate(2)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	29		Acute lymphoblastic leukemia(62;0.158)				ACTAATATTTGCTCTGATGGG	0.443	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													190	171	177	NA		NA	NA	9		NA											NA				100235814		2203	4300	6503	SO:0001583	missense			ENSG00000196116	HGNC:30831	NM_014290	Approved	uc004axj.3	NA	A6NCI6|B2RBX3|B4DG99|B4DXF7|E7EQD4|Q5VV27|Q96JT1|Q9UFF0|Q9Y2M3	ENST00000355295.4	37	CCDS6725.1	.	.	.	.	.	.	.	.	.	.	G	14.37	2.515821	0.44763	.	.	ENSG00000196116	ENST00000355295;ENST00000422139;ENST00000540902	T;T;T	0.30714	2.99;2.99;1.52	4.23	4.23	0.50019	Maternal tudor protein (1);	0.084537	0.85682	D	0.000000	T	0.28134	0.0694	M	0.63428	1.95	0.58432	D	0.999996	P;B	0.34934	0.476;0.068	B;B	0.35413	0.202;0.082	T	0.02654	-1.1128	10	0.09843	T	0.71	-14.0043	12.1121	0.53846	0.0:0.0:0.8278:0.1722	.	11;662	Q8NHU6-3;Q8NHU6	.;TDRD7_HUMAN	F	662;588;11	ENSP00000347444:C662F;ENSP00000413608:C588F;ENSP00000440717:C11F	ENSP00000347444:C662F	C	+	2	0	TDRD7	99275635	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	2.878000	0.48515	2.653000	0.90120	0.585000	0.79938	TGC	TDRD7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000053322.1	835.255568	KEEP		+	848.956114	0.35733	273	491	---	---	---	---	1	1	37	41	0	297	333	597	0	297	2	0	0	0	0	0	0	333	597	0	297	2	TP
CYP2E1	1571	broad.mit.edu	37	10	135351261	135351261	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr10:135351261G>C	ENST00000463117.2	+	10	1434	c.1162G>C	c.(1162-1164)Gtc>Ctc	p.V388L	SPRN_ENST00000541506.1_Intron|CYP2E1_ENST00000252945.3_Missense_Mutation_p.V388L			P05181	CP2E1_HUMAN	cytochrome P450, family 2, subfamily E, polypeptide 1	388		NA			drug metabolic process|heterocycle metabolic process|monoterpenoid metabolic process|steroid metabolic process|xenobiotic metabolic process	endoplasmic reticulum membrane|microsome	electron carrier activity|enzyme binding|heme binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding			NS(1)|central_nervous_system(3)|endometrium(1)|kidney(4)|large_intestine(6)|liver(2)|lung(7)|ovary(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	30		all_cancers(35;1.14e-09)|all_epithelial(44;5.79e-08)|Lung NSC(174;0.00263)|all_lung(145;0.0039)|all_neural(114;0.0299)|Melanoma(40;0.123)|Colorectal(31;0.172)|Glioma(114;0.203)		OV - Ovarian serous cystadenocarcinoma(35;1.12e-06)|all cancers(32;1.43e-06)|Epithelial(32;1.71e-06)	Acetaminophen(DB00316)|Chlorzoxazone(DB00356)|Cinnarizine(DB00568)|Clofibrate(DB00636)|Dacarbazine(DB00851)|Dapsone(DB00250)|Enflurane(DB00228)|Eszopiclone(DB00402)|Ethanol(DB00898)|Ethosuximide(DB00593)|Fomepizole(DB01213)|Glutathione(DB00143)|Halothane(DB01159)|Hexobarbital(DB01355)|Isoflurane(DB00753)|Isoniazid(DB00951)|Menadione(DB00170)|Mephenytoin(DB00532)|Methoxyflurane(DB01028)|Midazolam(DB00683)|Mitoxantrone(DB01204)|Nicotine(DB00184)|Nifedipine(DB01115)|Nitrofurantoin(DB00698)|Orphenadrine(DB01173)|Phenelzine(DB00780)|Quinidine(DB00908)|S-Adenosylmethionine(DB00118)|Sevoflurane(DB01236)|Theophylline(DB00277)|Tolbutamide(DB01124)	CTAGGGCACAGTCGTAGTGCC	0.398	NA	NA					NA		Naso-/Oropharyngeal/Laryngeal Cancer, Familial Clustering of					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													91	85	87	NA		NA	NA	10		NA											NA				135351261		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl.: Familial Head and Neck Cancer	ENSG00000130649	HGNC:2631	NM_000773	Approved	uc001lnj.1	NA	Q5VZD5|Q9UK47	ENST00000463117.2	37	CCDS7686.1	.	.	.	.	.	.	.	.	.	.	G	8.144	0.785857	0.16189	.	.	ENSG00000130649	ENST00000463117;ENST00000252945;ENST00000421586;ENST00000418356	T;T;T;T	0.67698	-0.28;-0.28;-0.28;-0.28	4.87	-0.357	0.12579	.	0.753028	0.13404	N	0.390432	T	0.45836	0.1362	N	0.20610	0.595	0.09310	N	1	B;B	0.21688	0.059;0.017	B;B	0.18871	0.023;0.006	T	0.26815	-1.0092	10	0.31617	T	0.26	.	8.1067	0.30890	0.5772:0.0:0.4228:0.0	.	284;388	Q59EW1;P05181	.;CP2E1_HUMAN	L	388;388;301;251	ENSP00000440689:V388L;ENSP00000252945:V388L;ENSP00000412754:V301L;ENSP00000397299:V251L	ENSP00000252945:V388L	V	+	1	0	CYP2E1	135201251	0.000000	0.05858	0.000000	0.03702	0.001000	0.01503	-0.022000	0.12480	0.047000	0.15862	-0.312000	0.09012	GTC	CYP2E1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051161.2	14.863419	KEEP		+	16.365037	0.227273	5	17	---	---	---	---	1	0.9050782	5	10	0	123	7	20	0	123	2	0	0	0	0	0	0	7	20	0	123	2	TP
TENM4	26011	broad.mit.edu	37	11	78440577	78440577	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr11:78440577T>C	ENST00000278550.7	-	22	3712	c.3250A>G	c.(3250-3252)Atc>Gtc	p.I1084V		NM_001098816.2	NP_001092286.2			teneurin transmembrane protein 4	NA		NA									NA						TTGAAGGGGATGGTCGGGTGG	0.567	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													59	66	64	NA		NA	NA	11		NA											NA				78440577		1979	4152	6131	SO:0001583	missense				HGNC:29945		Approved	uc021qoa.1	NA		ENST00000278550.7	37	CCDS44688.1	.	.	.	.	.	.	.	.	.	.	T	16.45	3.127512	0.56721	.	.	ENSG00000149256	ENST00000278550	D	0.89875	-2.58	4.73	4.73	0.59995	.	0.000000	0.85682	D	0.000000	D	0.86756	0.6009	N	0.10782	0.045	0.51767	D	0.999938	P	0.48640	0.913	P	0.61592	0.891	D	0.85804	0.1375	9	.	.	.	.	14.3756	0.66874	0.0:0.0:0.0:1.0	.	1084	Q6N022	TEN4_HUMAN	V	1084	ENSP00000278550:I1084V	.	I	-	1	0	ODZ4	78118225	1.000000	0.71417	1.000000	0.80357	0.991000	0.79684	4.921000	0.63397	1.974000	0.57490	0.402000	0.26972	ATC	TENM4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000391406.2	91.255446	KEEP		-	92.541728	0.365854	30	52	---	---	---	---	1	0.8083871	3	4	0	64	35	57	0	64	2	0	0	0	0	0	0	35	57	0	64	2	TP
AKAP11	11215	broad.mit.edu	37	13	42877884	42877884	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr13:42877884A>G	ENST00000025301.2	+	8	5177	c.5002A>G	c.(5002-5004)Agt>Ggt	p.S1668G		NM_016248.3	NP_057332.1	Q9UKA4	AKA11_HUMAN	A kinase (PRKA) anchor protein 11	1668		NA			intracellular protein kinase cascade	microtubule organizing center	protein kinase A binding|protein phosphatase 1 binding			breast(3)|central_nervous_system(4)|cervix(1)|endometrium(6)|kidney(3)|large_intestine(10)|liver(1)|lung(22)|ovary(1)|skin(3)|stomach(2)	56		Lung NSC(96;1.86e-05)|Prostate(109;0.0165)|Lung SC(185;0.0262)|Breast(139;0.0707)|Hepatocellular(98;0.114)		OV - Ovarian serous cystadenocarcinoma(117;0.000365)|GBM - Glioblastoma multiforme(144;0.00116)|BRCA - Breast invasive adenocarcinoma(63;0.19)		AGAGCTGAGCAGTACCAGCCT	0.507	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													37	36	36	NA		NA	NA	13		NA											NA				42877884		2203	4300	6503	SO:0001583	missense			ENSG00000023516	HGNC:369	NM_016248	Approved	uc001uys.2	NA	O75124|Q9NUK7	ENST00000025301.2	37	CCDS9383.1	.	.	.	.	.	.	.	.	.	.	A	4.112	0.018934	0.08006	.	.	ENSG00000023516	ENST00000025301	T	0.45668	0.89	5.67	5.67	0.87782	.	0.165154	0.49916	D	0.000133	T	0.23451	0.0567	N	0.08118	0	0.19775	N	0.99996	B	0.13145	0.007	B	0.06405	0.002	T	0.12811	-1.0533	10	0.30854	T	0.27	.	11.6813	0.51458	0.8599:0.0:0.0:0.1401	.	1668	Q9UKA4	AKA11_HUMAN	G	1668	ENSP00000025301:S1668G	ENSP00000025301:S1668G	S	+	1	0	AKAP11	41775884	0.992000	0.36948	0.880000	0.34516	0.032000	0.12392	3.899000	0.56288	2.148000	0.66965	0.482000	0.46254	AGT	AKAP11-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000044700.2	45.588458	KEEP		+	50.624012	0.2375	19	61	---	---	---	---	1	0.999355	5	41	0	81	21	73	0	81	2	0	0	0	0	0	0	21	73	0	81	2	TP
RCBTB2	1102	broad.mit.edu	37	13	49089796	49089796	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr13:49089796G>C	ENST00000344532.3	-	5	547	c.124C>G	c.(124-126)Cta>Gta	p.L42V	RCBTB2_ENST00000544904.1_Missense_Mutation_p.L18V|RCBTB2_ENST00000544492.1_5'UTR|RCBTB2_ENST00000481144.1_5'UTR|RCBTB2_ENST00000430805.2_Missense_Mutation_p.L47V	NM_001268.2	NP_001259.1	O95199	RCBT2_HUMAN	regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2	42		NA					Ran guanyl-nucleotide exchange factor activity			breast(5)|endometrium(3)|kidney(2)|large_intestine(2)|lung(11)|ovary(2)|prostate(3)|skin(3)	31		all_cancers(8;4.86e-71)|all_epithelial(8;2.11e-22)|Acute lymphoblastic leukemia(8;1.1e-21)|all_hematologic(8;2.3e-21)|all_lung(13;2.3e-10)|Lung NSC(96;1.07e-07)|Breast(56;1.53e-05)|Prostate(109;0.00174)|Hepatocellular(98;0.00826)|Myeloproliferative disorder(33;0.0179)|all_neural(104;0.0227)|Glioma(44;0.0286)|Lung SC(185;0.0301)		GBM - Glioblastoma multiforme(99;1.8e-09)|LUSC - Lung squamous cell carcinoma(3;0.116)		ATTAACTGTAGTTCTTCTTCA	0.363	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													85	88	87	NA		NA	NA	13		NA											NA				49089796		2203	4300	6503	SO:0001583	missense			ENSG00000136161	HGNC:1914	NM_001268	Approved	uc001vch.3	NA	B2RDW8	ENST00000344532.3	37	CCDS9411.1	.	.	.	.	.	.	.	.	.	.	G	10.57	1.387308	0.25031	.	.	ENSG00000136161	ENST00000344532;ENST00000450343;ENST00000452987;ENST00000430805;ENST00000544904	T;T;T	0.62364	0.03;0.04;0.85	6.04	4.23	0.50019	.	0.000000	0.85682	D	0.000000	T	0.47948	0.1473	L	0.49513	1.565	0.46458	D	0.999056	B;B;B;B	0.20887	0.049;0.003;0.028;0.003	B;B;B;B	0.18871	0.023;0.004;0.023;0.008	T	0.33266	-0.9875	10	0.11485	T	0.65	.	5.4475	0.16544	0.1925:0.0:0.5619:0.2455	.	18;47;46;42	B4DPP7;B4DWG0;B3KVB1;O95199	.;.;.;RCBT2_HUMAN	V	42;46;47;47;18	ENSP00000345144:L42V;ENSP00000389910:L47V;ENSP00000443904:L18V	ENSP00000345144:L42V	L	-	1	2	RCBTB2	47987797	0.994000	0.37717	0.912000	0.35992	0.984000	0.73092	2.216000	0.42871	1.537000	0.49254	0.561000	0.74099	CTA	RCBTB2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000044888.2	-15.694648	KEEP		-	9.381546	0.037037	4	104	---	---	---	---	1	0.5281856	3	48	0	182	4	129	0	182	2	0	0	0	0	0	0	4	129	0	182	2	TP
MT1A	4489	broad.mit.edu	37	16	56673190	56673190	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr16:56673190T>C	ENST00000290705.8	+	2	116	c.43T>C	c.(43-45)Tgc>Cgc	p.C15R	MT1JP_ENST00000564564.1_RNA	NM_005946.2	NP_005937.2	P04731	MT1A_HUMAN	metallothionein 1A	15	Beta.	NA				cytoplasm	cadmium ion binding|copper ion binding|zinc ion binding			endometrium(1)|large_intestine(1)|lung(1)	3						CTCCTGCACCTGCACTGGCTC	0.512	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													84	81	82	NA		NA	NA	16		NA											NA				56673190		2198	4300	6498	SO:0001583	missense				HGNC:7393	NM_005946	Approved	uc002ejq.3	NA	Q86YX5	ENST00000290705.8	37	CCDS32454.1	.	.	.	.	.	.	.	.	.	.	T	9.502	1.103425	0.20632	.	.	ENSG00000205362	ENST00000290705	T	0.34667	1.35	3.15	3.15	0.36227	Metallothionein domain, vertebrate (1);Metallothionein domain (1);	0.000000	0.64402	U	0.000003	T	0.55449	0.1921	.	.	.	0.80722	D	1	D	0.76494	0.999	D	0.87578	0.998	T	0.57171	-0.7857	9	0.54805	T	0.06	.	9.2532	0.37568	0.0:0.0:0.0:1.0	.	15	P04731	MT1A_HUMAN	R	15	ENSP00000290705:C15R	ENSP00000290705:C15R	C	+	1	0	MT1A	55230691	0.987000	0.35691	0.142000	0.22268	0.045000	0.14185	3.921000	0.56454	1.418000	0.47098	0.374000	0.22700	TGC	MT1A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000434324.1	-0.437289	KEEP		+	6.73953	0.093023	4	39	---	---	---	---	1	1	30	66	0	102	6	52	0	102	2	0	0	0	0	0	0	6	52	0	102	2	TP
TP53	7157	broad.mit.edu	37	17	7578555	7578555	+	Splice_Site	SNP	C	C	T			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr17:7578555C>T	ENST00000420246.2	-	5	508		c.e5-1		TP53_ENST00000455263.2_Splice_Site|TP53_ENST00000359597.4_Splice_Site|TP53_ENST00000445888.2_Splice_Site|TP53_ENST00000413465.2_Splice_Site|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000269305.4_Splice_Site	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	NA		NA			activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.?(39)|p.0?(8)|p.V73fs*9(1)|p.Y126fs*11(1)|p.P13fs*18(1)|p.T125_Y126insX(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		CAGGGGAGTACTGTAGGAAGA	0.552	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	51	Unknown(39)|Whole gene deletion(8)|Deletion - Frameshift(3)|Insertion - In frame(1)	ovary(9)|pancreas(6)|bone(5)|upper_aerodigestive_tract(4)|liver(4)|lung(4)|breast(4)|large_intestine(3)|central_nervous_system(3)|oesophagus(3)|haematopoietic_and_lymphoid_tissue(2)|stomach(1)|endometrium(1)|urinary_tract(1)|autonomic_ganglia(1)											42	42	42	NA		NA	NA	17		NA											NA				7578555		2203	4300	6503	SO:0001630	splice_region_variant	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	17.60	3.431133	0.62844	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000514944;ENST00000508793;ENST00000503591	.	.	.	4.87	3.9	0.45041	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.4246	0.50003	0.0:0.9094:0.0:0.0906	.	.	.	.	.	-1	.	.	.	-	.	.	TP53	7519280	1.000000	0.71417	0.999000	0.59377	0.918000	0.54935	7.639000	0.83342	1.359000	0.45940	0.655000	0.94253	.	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	174.034424	KEEP	Intron	-	174.985424	0.614458	51	32	---	---	---	---	1	1	3	223	0	62	53	40	0	62	2	1	1	139	57	0	136	53	40	0	62	2	TP
LRRC37A16P	0	broad.mit.edu	37	17	66126418	66126418	+	RNA	SNP	A	A	G			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr17:66126418A>G	ENST00000590019.1	-	0	343										NA		NA									NA						CCTCAATGCTATTTTTAAATT	0.413	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA										NA		ENST00000590019.1	37																																																																																				LRRC37A16P-002	KNOWN	basic	processed_transcript	NA	pseudogene	OTTHUMT00000450078.1	-30.263927	KEEP		-	9.126261	0.030675	5	158	---	---	---	---	1	0.1587966	8	18	1	318	5	217	1	318	2	0	0	0	0	0	0	5	217	1	318	2	TP
SGSH	6448	broad.mit.edu	37	17	78185892	78185892	+	Silent	SNP	G	G	A			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr17:78185892G>A	ENST00000326317.6	-	7	1013	c.927C>T	c.(925-927)agC>agT	p.S309S	SGSH_ENST00000570923.1_3'UTR|SGSH_ENST00000534910.1_Silent_p.S106S|SGSH_ENST00000572208.1_5'Flank	NM_000199.3	NP_000190.1	P51688	SPHM_HUMAN	N-sulfoglucosamine sulfohydrolase	309		NA			proteoglycan metabolic process	lysosome	metal ion binding|N-sulfoglucosamine sulfohydrolase activity|sulfuric ester hydrolase activity			central_nervous_system(1)|large_intestine(1)|lung(2)|ovary(1)|prostate(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	10	all_neural(118;0.0952)		OV - Ovarian serous cystadenocarcinoma(97;0.0292)|BRCA - Breast invasive adenocarcinoma(99;0.0908)			CGTAGGCCTCGCTGACTTGGC	0.617	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													73	60	65	NA		NA	NA	17		NA											NA				78185892		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:10818	NM_000199	Approved	uc002jxz.4	NA	A8K5E2	ENST00000326317.6	37	CCDS11770.1																																																																																			SGSH-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000437695.1	13.500203	KEEP		-	13.500203	0.5	4	4	---	---	---	---	1	0.9999991	23	53	0	70	6	5	0	70	2	0	0	0	0	0	0	6	5	0	70	2	TP
TRIP10	9322	broad.mit.edu	37	19	6751206	6751206	+	Missense_Mutation	SNP	G	G	A	rs139028261		GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr19:6751206G>A	ENST00000600428.1	+	14	1944	c.1298G>A	c.(1297-1299)cGa>cAa	p.R433Q	CTD-3128G10.6_ENST00000594056.1_RNA|TRIP10_ENST00000313285.8_Missense_Mutation_p.R541Q|TRIP10_ENST00000313244.9_Missense_Mutation_p.R597Q|TRIP10_ENST00000596758.1_Missense_Mutation_p.E551K			Q15642	CIP4_HUMAN	thyroid hormone receptor interactor 10	597	Interaction with CDC42.|Interaction with PDE6G (By similarity).	NA			actin cytoskeleton organization|cell communication|endocytosis|regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction	cell cortex|cell projection|cytoskeleton|cytosol|Golgi apparatus|lysosome|perinuclear region of cytoplasm|phagocytic cup	GTPase activator activity|identical protein binding|lipid binding			NS(1)|breast(1)|endometrium(1)|large_intestine(1)|liver(2)|lung(7)|ovary(1)|prostate(1)|urinary_tract(1)	16						TCCTACCTCCGAGTCACGCTC	0.612	NA	NA					NA						G	2	9e-04	0.0041	NA	2184	NA	0.9999	,	,	NA	4e-04	NA	NA	NA	9e-04	0.9304	EXOME	NA	NA	0.0033	SNP						NA		NA		NA		0								G	GLN/ARG	3,4403	6.2+/-15.9	0,3,2200	61	67	65	NA	1622	4.8	1	19	dbSNP_134	65	0,8600		0,0,4300	yes	missense	TRIP10	NM_004240.2	43	0,3,6500	AA,AG,GG	NA	0.0,0.0681,0.0231	benign	541/546	6751206	3,13003	2203	4300	6503	SO:0001583	missense			ENSG00000125733	HGNC:12304		Approved	uc002mfr.3	NA	B2R8A6|B7WP22|D6W645|O15184|Q53G22|Q5TZN1|Q6FI24|Q8NFL1|Q8TCY1|Q8TDX3|Q96RJ1	ENST00000600428.1	37		2|2	9.157509157509158E-4|9.157509157509158E-4	2|2	0.0040650406504065045|0.0040650406504065045	0|0	0.0|0.0	0|0	0.0|0.0	0|0	0.0|0.0	G|G	11.40|11.40	1.626713|1.626713	0.28978|0.28978	6.81E-4|6.81E-4	0.0|0.0	ENSG00000125733|ENSG00000125733	ENST00000420690|ENST00000313285;ENST00000313244	.|T;T	.|0.16196	.|2.36;3.4	4.84|4.84	4.84|4.84	0.62591|0.62591	.|Src homology-3 domain (3);	.|0.569877	.|0.16222	.|N	.|0.224005	T|T	0.11495|0.11495	0.0280|0.0280	N|N	0.00670|0.00670	-1.27|-1.27	0.32213|0.32213	N|N	0.576258|0.576258	B|D;D	0.12630|0.64830	0.006|0.994;0.979	B|D;P	0.06405|0.64042	0.002|0.921;0.511	T|T	0.18147|0.18147	-1.0346|-1.0346	8|10	0.87932|0.41790	D|T	0|0.15	-11.8101|-11.8101	9.2393|9.2393	0.37486|0.37486	0.0967:0.0:0.9033:0.0|0.0967:0.0:0.9033:0.0	.|.	551|597;541	G5E9U1|Q15642;Q15642-2	.|CIP4_HUMAN;.	K|Q	551|541;597	.|ENSP00000320493:R541Q;ENSP00000320117:R597Q	ENSP00000415493:E551K|ENSP00000320117:R597Q	E|R	+|+	1|2	0|0	TRIP10|TRIP10	6702206|6702206	0.171000|0.171000	0.23029|0.23029	0.963000|0.963000	0.40424|0.40424	0.150000|0.150000	0.21749|0.21749	2.065000|2.065000	0.41442|0.41442	2.678000|2.678000	0.91216|0.91216	0.305000|0.305000	0.20034|0.20034	GAG|CGA	TRIP10-014	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000458012.1	110.587079	KEEP		+	111.287385	0.622642	33	20	---	---	---	---	1	1	46	85	0	199	41	26	0	199	2	0	0	0	0	0	0	41	26	0	199	2	TP
MCHR1	0	broad.mit.edu	37	22	41077826	41077826	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2629-Tumor-SM-17P3J	GBM-TCGA-19-2629-Normal-SM-1QXXP	g.chr22:41077826G>A	ENST00000249016.4	+	2	1859	c.1163G>A	c.(1162-1164)cGc>cAc	p.R388H	MCHR1_ENST00000381433.2_Missense_Mutation_p.R262H|MCHR1_ENST00000498400.1_3'UTR	NM_005297.3	NP_005288.3	Q99705	MCHR1_HUMAN	melanin-concentrating hormone receptor 1	388		NA			elevation of cytosolic calcium ion concentration|feeding behavior|generation of precursor metabolites and energy|inhibition of adenylate cyclase activity by G-protein signaling pathway	integral to plasma membrane|nonmotile primary cilium	neuropeptide receptor activity			endometrium(5)|large_intestine(7)|lung(6)|pancreas(1)|urinary_tract(1)	20						GAGACGTTCCGCAAACGCTTG	0.572	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													111	90	97	NA		NA	NA	22		NA											NA				41077826		2203	4300	6503	SO:0001583	missense			ENSG00000128285	HGNC:4479		Approved	uc003ayz.3	NA	B2RBX6|Q5R3J1|Q96S47|Q9BV08	ENST00000249016.4	37	CCDS14004.1	.	.	.	.	.	.	.	.	.	.	G	21.8	4.209252	0.79240	.	.	ENSG00000128285	ENST00000249016;ENST00000381433	T;T	0.58358	0.34;0.34	5.4	5.4	0.78164	.	0.101947	0.64402	D	0.000008	T	0.57286	0.2043	N	0.19112	0.55	0.41286	D	0.986946	D	0.76494	0.999	P	0.62184	0.899	T	0.62955	-0.6744	10	0.87932	D	0	.	17.0403	0.86487	0.0:0.0:1.0:0.0	.	388	Q99705	MCHR1_HUMAN	H	388;262	ENSP00000249016:R388H;ENSP00000370841:R262H	ENSP00000249016:R388H	R	+	2	0	MCHR1	39407772	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	4.226000	0.58606	2.698000	0.92095	0.655000	0.94253	CGC	MCHR1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000317142.1	79.857981	KEEP		+	99.507754	0.182692	38	170	---	---	---	---	1	0.9998624	7	52	0	220	49	206	0	220	2	0	0	0	0	0	0	49	206	0	220	2	TP
